Related references
Note: Only part of the references are listed.Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis
Rovina Ruslami et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2022)
High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial
Fiona Cresswell et al.
CLINICAL INFECTIOUS DISEASES (2021)
Visualizing the dynamics of tuberculosis pathology using molecular imaging
Alvaro A. Ordonez et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone
Laura J. Whitworth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant-associated infections
Oren Gordon et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography
Alvaro A. Ordonez et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial
Anthony J. Garcia-Prats et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials
Elin M. Svensson et al.
CLINICAL INFECTIOUS DISEASES (2020)
Mapping the Fine-Scale Organization and Plasticity of the Brain Vasculature
Christoph Kirst et al.
CELL (2020)
Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions
Alvaro A. Ordonez et al.
NATURE MEDICINE (2020)
Phase 0/microdosing approaches: time for mainstream application in drug development?
Tal Burt et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Early Mortality among Immunocompetent Patients of Tuberculous Meningitis: A Prospective Study
Ravi Shekhar Jaipuriar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Molecular imaging of bacterial infections: Overcoming the barriers to clinical translation
Alvaro A. Ordonez et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Characterization of Brain Inflammation, Apoptosis, Hypoxia, Blood-Brain Barrier Integrity and Metabolism in Venezuelan Equine Encephalitis Virus (VEEV TC-83) Exposed Mice by In Vivo Positron Emission Tomography Imaging
Thomas M. Bocan et al.
VIRUSES-BASEL (2019)
Mortality in hospitalized patients with tuberculous meningitis
Jaime Soria et al.
BMC INFECTIOUS DISEASES (2019)
Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation
Catherine A. Foss et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study
Arjan van Laarhoven et al.
LANCET INFECTIOUS DISEASES (2018)
Tuberculous meningitis: a roadmap for advancing basic and translational research
Sanjay K. Jain et al.
NATURE IMMUNOLOGY (2018)
An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
Nastasia K-H Lim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Hypoxia increases neutrophil-driven matrix destruction after exposure to Mycobacterium tuberculosis
Catherine W. M. Ong et al.
SCIENTIFIC REPORTS (2018)
Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis
Elizabeth W. Tucker et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
Martin J. Boeree et al.
LANCET INFECTIOUS DISEASES (2017)
Tuberculous meningitis
Robert J. Wilkinson et al.
NATURE REVIEWS NEUROLOGY (2017)
Preclinical Efficacy Testing of New Drug Candidates
Eric L. Nuermberger
MICROBIOLOGY SPECTRUM (2017)
Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
Soumya Swaminathan et al.
CLINICAL INFECTIOUS DISEASES (2016)
Microglia activation in a pediatric rabbit model of tuberculous meningitis
Elizabeth W. Tucker et al.
DISEASE MODELS & MECHANISMS (2016)
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
A. Dorothee Heemskerk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Facile room temperature synthesis of fluorine-18 labeled fluoronicotinic acid-2,3,5,6-tetrafluorophenyl ester without azeotropic drying of fluorine-18
Falguni Basuli et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Synthesis of fluorine-18 radio-labeled serum albumins for PET blood pool imaging
Falguni Basuli et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
Emmanuel Chigutsa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Radioiodinated DPA-713 Imaging Correlates with Bactericidal Activity of Tuberculosis Treatments in Mice
Alvaro A. Ordonez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis
Silvia S. Chiang et al.
LANCET INFECTIOUS DISEASES (2014)
Noninvasive Molecular Imaging of Tuberculosis-Associated Inflammation With Radioiodinated DPA-713
Catherine A. Foss et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Jotam G. Pasipanodya et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
Rovina Ruslami et al.
LANCET INFECTIOUS DISEASES (2013)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
Roland Nau et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Nitric Oxide Is Involved in Mycobacterium bovis Bacillus Calmette-Guerin-Activated Jagged1 and Notch1 Signaling
Nisha Kapoor et al.
JOURNAL OF IMMUNOLOGY (2010)
Pathogenesis of Central Nervous System Tuberculosis
Nicholas A. Be et al.
CURRENT MOLECULAR MEDICINE (2009)
Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment
Una Rauchhaus et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy
Fadoua Saadani-Makki et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Murine Model to Study the Invasion and Survival of Mycobacterium tuberculosis in the Central Nervous System
Nicholas A. Be et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Modulation of P-glycoprotein at the blood-brain barrier: Opportunities to improve central nervous system pharmacotherapy
David S. Miller et al.
PHARMACOLOGICAL REVIEWS (2008)
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A new murine model to study the pathogenesis of tuberculous meningitis
Gijs Th. J. van Well et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis
SK Jain et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Ontogeny of the human central nervous system: What is happening when?
Victorine B. de Graaf-Peters et al.
EARLY HUMAN DEVELOPMENT (2006)
The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses
CP Simmons et al.
JOURNAL OF IMMUNOLOGY (2005)
Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants
AR Stark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis
T Böttcher et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
